Genetic predisposition to in situ and invasive lobular carcinoma of the breast. PloS Genet. 2014; 10(4):e1004285.
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer. 2014; 110(4):1088-100.
Reproducibility of Estradiol and Testosterone Levels in Postmenopausal Women Over 5 Years: Results from the Breakthrough Generations Study. Am J Epidemiol. 2014;179(9):1128-33.
Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study. Br J Cancer. 2014;110(7):1898-907.
Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast Cancer Res. 2014;16:R18.
DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet. 2014;23(9):2490-7.
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet. 2014; 23(7):1934-46.
Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene-Environment Interactions. Genet Epidemiol. 2014; 38(1):84-93.
Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med. 2014;16(1):19-24.
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1. Am J Hum Genet. 2013; 93(6):1046-60.